Itinerary: Clinical and Therapeutic Profile of Brain Tumors


Authors : H. Fares; S. Abdou; M. Taouchikht; K. Nouni; A. Lachgar; H. El Kacemi; T. Kebdani; K. Hassouni

Volume/Issue : Volume 9 - 2024, Issue 7 - July

Google Scholar : https://tinyurl.com/m5tuw3pb

Scribd : https://shorturl.at/bS1Yf

DOI : https://doi.org/10.38124/ijisrt/IJISRT24JUL1253

PlumX Metrics

Semantic Scholar

ResearchGate

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Introduction Brain tumors, defined by the abnormal proliferation of anaplastic cells within the brain meninges or cranial nerves, remain significant contributors to morbidity and mortality despite advances in imaging techniques like MRI, PET, and SPECT, and neuro-oncological therapies. Histological types of these tumors vary by age. This study aims to outline the epidemiological and histological profiles of central nervous system (CNS) tumors at the National Institute of Oncology in Rabat, Morocco.  Materials and Methods A retrospective descriptive study was conducted on patients treated at the radiotherapy department from November 2018 to October 2021. Parameters such as age, sex, primary clinical signs, tumor origin for secondary lesions, tumor location, and histological types were analyzed.  Results 182 cases of CNS tumors were recorded, with a median patient age of 43 years (range 8-73 years). Women represented 73.2% of the cases, and children made up 8.5% of the study population. The most common symptoms at diagnosis were headaches (68.3%), decreased visual acuity (28%), and nausea/vomiting (24.4%). Tumors were mostly located above the tentorium (80%). Of the tumors, 49% were secondary, primarily originating from the breast (58.6%) and lungs (46%). Glioblastoma was the most common primary tumor (39.1%), with a mortality rate of 55%. Multidisciplinary care is crucial for addressing the challenges posed by this serious prognosis.  Conclusion CNS tumors are uncommon in Morocco and are generally observed in adults, mainly secondary to breast cancer. Glioblastoma is the most frequent primary tumor. Effective multidisciplinary approaches are necessary to manage these complex cases.

Keywords : Epidemiology, Tumor, Central Nervous System.

References :

  1. Sung H,Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin. 2021 May;71(3):209–49. DOI: 10.3322/caac.21660
  2. Cancertoday [Internet]. 2021. Available from: http://gco.iarc.fr/today/home
  3. McNeill KA. Epidemiology of Brain Tumors. Neurologic Clinics. 2016 Nov;34(4):981–98.DOI: 10.1016/j.ncl.2016.06.014
  4. Tongavelona A, Randrianjisandrotra O, Ramidrsoa AL, Raobela L, Ratovondrainy W, Randrianjafisamindrakotroka NS. Tumors of the central nervous system in Antananarivo Madagascar. African Journal of Neurological Sciences. 2019;38(1):28–37.
  5. Miller KD,Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, et al. Brain and other central nervous system tumor statistics, 2021. CA A Cancer J Clin. 2021 Sep;71(5):381–406. DOI: 10.3322/caac.21693
  6. Wells EM, Packer RJ.Pediatric Brain Tumors: CONTINUUM: Lifelong Learning in Neurology. 2015 Apr;21:373–96. DOI: 10.1212/01.CON.0000464176.96311.d1
  7. https://www.arcagy.org/infocancer/localizations/autretypes-de-cancers/cerebral-tumors/disease/lepidemiology.html.
  8. Pouchieu C, Baldi I, Gruber A et al. Descriptive epidemiology and risk factors of primary central nervous system tumors: Current knowledge. Rev Neurol (Paris) 2016;172(1):46-55.
  9. https://braintumourregistry.ca/wpcontent/uploads/2021/05/Incidence-and-MortalityReport-2021-02-01_eng-CA-Review-Final-to-RA-1.pdf Accessed 03/23/22
  10. Leece R, Xu J, Ostrom QT, Chen Y, Kruchko C, Barnholtz-Sloan JS. Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007. Neuro-Oncology. 2017 Oct 19;19(11):1553–64.
  11. Mondal S, Pradhan R, Pal S, Biswas B, Banerjee A,Bhattacharyya D. Clinicopathological pattern of brain tumors: A 3-year study in a tertiary care hospital in India.Clin Cancer Investig J. 2016;5(5):437 . DOI: 10.4103/2278-0513.197861
  12. Darlix A, Zouaoui S, Rigau V et al. Epidemiology for primary brain tumors: a nationwide population-based study. J Neurooncol 2017;131(3):525-46.
  13. Bauchet L. Epidemiology of primary brain tumors. The Neurologist's Letter 2018 Vol. XXII - n°5: 124-9
  14. Perkins A, Liu G.Primary Brain Tumors in Adults: Diagnosis and Treatment. Am Fam Physician. 2016; 93(3):211-7. Drappatz J. Medical Care of Patients With Brain Tumors. CONTINUUM: Lifelong Learning in Neurology.2012;18:275–94.
  15. Butowski NA. Epidemiology and Diagnosis of Brain Tumors. CONTINUUM: Lifelong Learning in Neurology. 2015;21:301–13.
  16. Kirby S,Purdy RA. Headaches and Brain Tumors.Neurologic Clinics. 2014 May;32(2):423–32. DOI: 10.1016/j.ncl.2013.11.006
  17. Vecht CJ,Kerkhof M, Duran-Pena A. Seizure Prognosis in Brain Tumors: New Insights and Evidence-Based Management. The Oncologist. 2014 Jul 1;19(7):751–9. DOI: 10.1634/theoncologist.2014-0060
  18. Klinger NV, Shah AK, Mittal S. Management ofbrain tumor-related epilepsy. Neurol India. 2017;65(Supplement): S60–70.
  19. Leung D, HanMikkelsen T, Nabors LB. Role of MRI in Primary Brain Tumor Evaluation. J Natl Compr Canc Netw. 2014 Nov;12(11):1561–8. DOI: 10.6004/jnccn.2014.0156
  20. Fink K, Fink J. Imaging ofbrain metastases. Surg Neurol Int. 2013;4(5):209. DOI: 10.4103/2152-7806.111298
  21. Orringer DA, Golby A, Jolesz F. Neuronavigation in the surgical management of brain tumors: current and future trends. Expert Review of Medical Devices. 2012 Sep;9(5):491–500. DOI: 10.1586/erd.12.42
  22. Jung TY, Jung S, Kim IY, Park SJ, Kang SS, Kim SH, et al. Application ofNeuronavigation System to Brain Tumor Surgery with Clinical Experience of 420 Cases. Minimally Invasive Neurosurg. 2006 Aug;49(4):210–5.DOI: 10.1055/s-2006-948305
  23. Newton HB,Malkin MG. Intracranial metastases. Boca Raton: CRC Press; 2010 p. 23–39. (Neurological Complications of Systemic Cancer and Antineoplastic Therapy, 1st edition).
  24. Taillibert S, LeRhun É. Epidemiology of brain metastatic lesions. Cancer/Radiotherapy. 2015 Feb;19(1):3–9.DOI: 10.1016/j.canrad.2014.11.001
  25. Hecht SS. Tobacco SmokeCarcinogens and Lung Cancer. JNCI Journal of the National Cancer Institute. 1999 Jul 21;91(14):1194–210.DOI: 10.1093/jnci/91.14.1194
  26. PerezWarnisher MT, by Miguel M del PC, Seijo LM. Tobacco Use Worldwide: Legislative Efforts to Curb Consumption. Annals of Global Health. 2019 Jan 22;85(1):9. DOI: 10.5334/aogh.2417
  27. Olasode BJ, Shokunbi MT, Aghadiuno PU. Intracranial neoplasms in Ibadan, Nigeria. East Afr Med J. 2000 Jan;77(1):4–8.
  28. Ostrom QT, Gittleman H, Stetson L, Virk SM, Barnholtz-Sloan JS. Epidemiology of Gliomas. In: RaizerJ, Parsa A, editors. Current Understanding and Treatment of Gliomas [Internet]. Cham: Springer International Publishing; 2015 [cited 2022 Mar 17]. p. 1–14. (Cancer Treatment and Research; vol. 163). Available from: http://link.springer.com/10.1007/978-3-319-12048-5_1 DOI: 10.1007/978-3-319-12048-5_1
  29. Wirsching HG, Galanis E, Weller M. Glioblastoma. In:Handbook of Clinical Neurology [Internet]. Elsevier; 2016 [cited 2022 Mar 17]. p. 381–97. Available from:https://linkinghub.elsevier.com/retrieve/pii/B9780128029978000232 DOI: 10.1016/B978-0-12-802997-8.00023-2

Introduction Brain tumors, defined by the abnormal proliferation of anaplastic cells within the brain meninges or cranial nerves, remain significant contributors to morbidity and mortality despite advances in imaging techniques like MRI, PET, and SPECT, and neuro-oncological therapies. Histological types of these tumors vary by age. This study aims to outline the epidemiological and histological profiles of central nervous system (CNS) tumors at the National Institute of Oncology in Rabat, Morocco.  Materials and Methods A retrospective descriptive study was conducted on patients treated at the radiotherapy department from November 2018 to October 2021. Parameters such as age, sex, primary clinical signs, tumor origin for secondary lesions, tumor location, and histological types were analyzed.  Results 182 cases of CNS tumors were recorded, with a median patient age of 43 years (range 8-73 years). Women represented 73.2% of the cases, and children made up 8.5% of the study population. The most common symptoms at diagnosis were headaches (68.3%), decreased visual acuity (28%), and nausea/vomiting (24.4%). Tumors were mostly located above the tentorium (80%). Of the tumors, 49% were secondary, primarily originating from the breast (58.6%) and lungs (46%). Glioblastoma was the most common primary tumor (39.1%), with a mortality rate of 55%. Multidisciplinary care is crucial for addressing the challenges posed by this serious prognosis.  Conclusion CNS tumors are uncommon in Morocco and are generally observed in adults, mainly secondary to breast cancer. Glioblastoma is the most frequent primary tumor. Effective multidisciplinary approaches are necessary to manage these complex cases.

Keywords : Epidemiology, Tumor, Central Nervous System.

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe